Delivery devices

Information

  • Patent Grant
  • 10639438
  • Patent Number
    10,639,438
  • Date Filed
    Monday, March 26, 2018
    6 years ago
  • Date Issued
    Tuesday, May 5, 2020
    4 years ago
Abstract
A delivery device for delivering a metered amount of substance (L) in response to exhalation by a user, the delivery device comprising: a mouthpiece (5) through which the user in use exhales; an outlet (45) from which substance Is delivered; and a dispensing unit (35) which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member (37) which includes a cavity (39) for containing a metered amount of substance, an outlet nozzle (43) which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing (41) member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
Description

The present invention relates to a delivery device for and method of delivering a metered volume of substance, in particular a delivery device for delivering a metered volume of a liquid substance to a nasal cavity of a subject.


Very many delivery devices exist for the delivery of liquid substances, which typically comprise a manually-actuated pump for the delivery of a liquid substance as an aerosol spray.


Whilst these delivery devices have found extensive application, the present inventors have recognized the need for a delivery device which utilizes the exhalation breath of a user as the driving force to deliver a metered dose of a liquid substance.


In one aspect the present invention provides a delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising: a mouthpiece through which the user in use exhales; an outlet from which substance is delivered; and a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.


In one embodiment the cavity is an elongate cavity.


In one embodiment the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.


In one embodiment the ball sealingly engages with an inner peripheral wall of the cavity.


In one embodiment the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and preferably less than about 3 kPa.


In one embodiment the outlet nozzle provides for an aerosol spray.


In one embodiment the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from exit of the outlet nozzle.


In another embodiment the outlet nozzle provides for a jet.


In one embodiment the delivery device further comprises: a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.


In one embodiment the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.


In one embodiment the delivery device further comprises: a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.


In one embodiment the delivery device further comprises: a baffle member which is disposed in the fluid communication path.


In one embodiment the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit.


In one embodiment the baffle member includes a plurality of entraining air flow channels.


In one embodiment the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.


In one embodiment the housing includes an outlet chamber downstream of the baffle member.


In one embodiment the outlet chamber surrounds the dispensing unit.


In one embodiment the outlet includes a flow restrictor for providing a flow restriction thereat.


In one embodiment the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece.


In one embodiment the flow restrictor has a frusto-conical section.


In one embodiment the delivery device further comprises: a flow regulator which is disposed at the outlet nozzle of the dispensing unit.


In one embodiment the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.


In one embodiment the delivery device is configured to deliver a liquid.


In one embodiment the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.





A preferred embodiment of the present invention will now be described hereinbelow by way of example only with reference to the accompanying drawings, in which:



FIG. 1 illustrates a part-sectional perspective view of a delivery device in accordance with a preferred embodiment of the present invention;



FIG. 2 illustrates a longitudinal sectional view of the delivery device of FIG. 1, where in the rest or non-actuated state;



FIGS. 3(a) to (c) illustrate three delivery profiles for the delivered substance obtainable by the delivery device of FIG. 1;



FIG. 4 illustrates the delivery device of FIG. 1, where in the actuated state;



FIG. 5 illustrates a part-sectional perspective view of a delivery device as a modification of the delivery device of FIG. 1; and



FIG. 6 illustrates a longitudinal sectional view of the delivery device of FIG. 5.





The delivery device comprises a first, inlet housing part 3 which defines a mouthpiece 5 at one, inlet end thereof and an inlet chamber 7 which is in fluid communication with the mouthpiece 5 and the other, outlet end of which is open, such that exhalation by a user into the mouthpiece 5 delivers an air flow into the inlet chamber 7 and to the open, outlet end thereof.


In this embodiment the mouthpiece 5 comprises a tubular section which is gripped in the lips of the user.


In this embodiment the inlet chamber 7 flares outwardly from the mouthpiece 5, here having a frusto-conical section.


The delivery device further comprises a baffle member 11 which sealingly engages the open, outlet end of the inlet chamber 7, such as to direct the air flow as delivered through the inlet chamber 7.


The baffle member 11 includes a first, driving air pressure channel 21 at which a driving pressure is created, which acts to drive a liquid dispensing unit 35, as will be described in more detail hereinbelow, and at least one, in this embodiment a plurality of second, entraining air flow channels 23 through which an entraining air flow F is delivered.


In this embodiment the first, driving air pressure channel 21 is located on the longitudinal axis of the inlet chamber 7. In this embodiment the driving air pressure channel 21 has a circular section, here having a diameter of at or less than about 6 mm.


In this embodiment the entraining air flow channels 23 are located such as to be in fluid communication with the periphery of the open, outlet end of the inlet chamber 7. In this embodiment the baffle member 11 includes four entraining air flow channels 23 which are disposed uniformly on an annulus about the longitudinal axis of the inlet housing part 3, and each have a circular section, here having a diameter of at or less than about 4 mm.


In this embodiment the baffle member 11 comprises first and second baffle elements 25, 27, here plates which are disposed in juxtaposed relation.


The delivery device further comprises a pressure regulator 29 which includes an aperture 31 which is fluidly connected to the driving air pressure channel 21 in the baffle member 11, in this embodiment at the downstream end thereof, such as to provide for the generation of a predetermined pressure thereat. In this embodiment the aperture 31 has a circular section, here having a diameter of at or less than about 4 mm.


The delivery device further comprises a liquid dispensing unit 35 which is fluidly connected to the pressure regulator 29 such as to be actuated by the driving air pressure P as generated on exhalation by the user through the mouthpiece 5.


The liquid dispensing unit 35 comprises a body member 37, in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L, a dispensing member 41 which is movably disposed in the cavity 39, such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39, and an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.


In this embodiment the cavity 39 has a volume of about 1 ml. In another embodiment the cavity 39 could have a volume of or less than about 200 μl.


In this embodiment the dispensing member 41 is initially disposed at one end of the cavity 39 adjacent the flow regulator 29 and is moved to the other end of the cavity 39 under the action of the driving air pressure, with the liquid L as contained in the cavity 39 being progressively dispensed as the dispensing member 41 is moved along the cavity 39.


In this embodiment the dispensing member 41 and the cavity 39 of the liquid dispensing unit 35 are configured to provide for movement with a driving air pressure P at or less than about 5 kPa and preferably at or less than about 3 kPa.


In this embodiment the dispensing member 41 is a ball which sealingly engages the peripheral wall of the cavity 39.


The outlet nozzle 43 includes an outlet orifice 45 which is shaped and dimensioned, in this embodiment having a circular section, to provide the dispensed liquid with a predetermined profile. In this embodiment the outlet orifice 45 is configured to dispense the liquid L such that the flow of liquid L remains substantially rectilinear for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from the exit of the outlet orifice 45 and thereafter provide a dispersed aerosol spray, as illustrated in FIG. 3(a). In an alternative embodiment the outlet orifice 45 can be configured to provide a liquid jet, either with some dispersion in the form of a shower of droplets, as illustrated in FIG. 3(b), or with no dispersion, as illustrated in FIG. 3(c).


In preferred embodiments the outlet orifice 45 has a diameter of at or less than about 3 mm, preferably at or less than about 2 mm, and more preferably at or less than about 1 mm.


In this embodiment the outlet nozzle 43 includes a frangible membrane which normally encloses the outlet orifice 45 thereof such as to contain the liquid L and is ruptured on the application of the driving air pressure P to the liquid L.


The delivery device further comprises a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57, in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35, which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.


The delivery device further comprises a flow regulator 61 which encloses the annular outlet chamber 57 at the outlet end of the body member 37 of the liquid dispensing unit 35.


In this embodiment the flow regulator 61 includes a plurality of flow apertures 63, in this embodiment sixteen apertures, which are located on an annulus surrounding the body member 37 of the liquid dispensing unit 35, such as to provide for the delivery of a substantially annular entraining air flow F which entrains the liquid L as dispensed from the liquid-containing cavity 39 of the liquid dispensing unit 35.


In this embodiment the flow regulator 61 is configured to provide for a flow rate of at least about 20 l/min, more preferably at least about 30 l/min, still more preferably at least about 40 l/min and yet more preferably at least about 50 l/min.


In this embodiment the flow apertures 63 have a circular section, here of a diameter of at or less than about 1 mm.


Operation of the above-described delivery device will now be described hereinbelow with reference to FIG. 4 of the accompanying drawings.


A user first inserts the nosepiece 53 into one of his/her nostrils and then grips the mouthpiece 5 in his/her lips. It should be understood that, for the sake of ease of illustration, the delivery device has been illustrated in an elongate configuration where the nosepiece 53 and the mouthpiece 5 are located on a common axis. In practice, the nosepiece 53 and the mouthpiece 5 would be inclined relative to one another, such as to facilitate fitting of the nosepiece 53 and the mouthpiece 5 in respective ones of a nostril and the lips.


The user then exhales through the mouthpiece 5, which is in fluid communication with the inlet chamber 7.


This exhalation acts to generate a driving air pressure P at the driving air pressure channel 21 in the baffle member 11 and an entraining air flow F through the entraining air flow channels 23 in the baffle member 11, which entraining air flow F continues through the outlet chamber 57 and the flow apertures 63 in the entraining air flow regulator 61, which define a substantially annular entraining air flow F which surrounds the outlet end of the liquid dispensing unit 35.


The driving air pressure P as created at the driving air pressure channel 21 simultaneously acts on the dispensing member 41, which is located in the cavity 39 of the liquid dispensing unit 35, such as to move the same along the cavity 39 and dispense the liquid L as contained therein from the outlet end thereof into the entraining air flow F, which surrounds the same, thereby providing for delivery of the liquid L, in this embodiment into the nasal cavity of the user.


In this embodiment the delivery device, in providing for the delivery of the liquid L in an entraining air flow F, advantageously provides for delivery into and through the nasal airway in the manner as described in the applicant's earlier WO-A-2000/051672, the content of which is herein incorporated by reference.


Finally, it will be understood that the present invention has been described in its preferred embodiment and can be modified in many different ways without departing from the scope of the invention as defined by the appended claims.


In one modification, as illustrated in FIGS. 5 and 6, the delivery device can further comprise a flow restrictor 71 at the outlet end of the outlet housing part 51 which defines the nosepiece 53. In this embodiment the flow restrictor 71 tapers inwardly, here with a frusto-conical section 73, towards the outlet end of the outlet housing part 51. In this embodiment the flow restrictor 71 defines an outlet which has a circular section. In preferred embodiments the outlet of the flow restrictor 71 has a diameter of at or less than about 8 mm, preferably at or less than about 6 mm and more preferably at or less than about 4 mm, and the angle of the tapering section 73 of the flow restrictor 71 has an angle of at or less than about 60 degrees, preferably at or less than about 55 degrees and more preferably at or less than about 52 degrees relative to a plane perpendicular to the longitudinal axis of the outlet housing part 51. With this configuration, a faster delivery of the liquid L can be achieved as compared to the above-described embodiment.

Claims
  • 1. A delivery device for delivering a substance in response to exhalation by a user, the delivery device comprising: a mouthpiece adapted for the user to exhale through;an outlet from which the substance is delivered; anda dispensing unit operable to dispense a metered amount of the substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member, the body member including a cavity containing the substance, an outlet nozzle fluidly connected to the cavity from which the substance is delivered, and a dispensing member movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by the exhalation of the user, causing the metered amount of the substance to be delivered from the outlet nozzle;whereby the exhalation by the user creates an exhalation flow adapted to directly act on the dispensing member.
  • 2. The delivery device of claim 1, wherein the cavity is an elongate cavity.
  • 3. The delivery device of claim 2, wherein the cavity has a cylindrical section and the dispensing member comprises a ball.
  • 4. The delivery device of claim 3, wherein the ball sealingly engages an inner peripheral wall of the cavity.
  • 5. The delivery device of claim 1, wherein the dispensing member is configured to move within the cavity when the driving pressure is less than 5 kPa.
  • 6. The delivery device of claim 1, wherein the outlet nozzle is configured to deliver an aerosol spray.
  • 7. The delivery device of claim 6, wherein the outlet nozzle provides for a rectilinear flow for a distance of at least 30 mm from an exit of the outlet nozzle.
  • 8. The delivery device of claim 1, wherein the outlet nozzle is configured to deliver a jet.
  • 9. The delivery device of claim 1, further comprising a pressure regulator fluidly connected to the dispensing unit and configured to apply a predeterminable driving pressure to the dispensing member.
  • 10. The delivery device of claim 1, further comprising a housing defining a fluid communication path between the mouthpiece and the outlet.
  • 11. The delivery device of claim 10, further comprising a baffle member disposed in the fluid communication path.
  • 12. The delivery device of claim 11, wherein the baffle member includes a first, driving air pressure channel fluidly connected to the dispensing unit and at least one second, entraining air flow channel fluidly connected to the mouthpiece through which an entraining air flow is delivered for entraining the substance as delivered by the dispensing unit.
  • 13. The delivery device of claim 12, wherein the baffle member includes a plurality of entraining air flow channels.
  • 14. The delivery device of claim 11, wherein the housing includes an inlet chamber upstream of the baffle member and downstream of the mouthpiece which flares outwardly from the mouthpiece toward the baffle member.
  • 15. The delivery device of claim 11, wherein the housing includes an outlet chamber downstream of the baffle member.
  • 16. The delivery device of claim 15, wherein the outlet chamber surrounds the dispensing unit.
  • 17. The delivery device of claim 16, further comprising: an annulus surrounding the outlet nozzle of the dispensing unit and positioned radially between the dispensing unit and the housing.
  • 18. The delivery device of claim 17, wherein the annulus includes a plurality of flow apertures.
  • 19. The delivery device of claim 1, wherein the outlet includes a flow restrictor.
  • 20. The delivery device of claim 19, wherein the flow restrictor tapers inwardly.
  • 21. The delivery device of claim 20, wherein the flow restrictor has a frusto-conical section.
  • 22. The delivery device of claim 1, where the delivery device is configured to deliver a liquid.
  • 23. The delivery device of claim 1, wherein the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering the substance to a nasal airway of the user.
Priority Claims (1)
Number Date Country Kind
0623731.7 Nov 2006 GB national
Parent Case Info

This application is a continuation application of U.S. application Ser. No. 15/133,356, filed on Apr. 20, 2016, which is a continuation application of U.S. application Ser. No. 14/171,554, filed on Feb. 3, 2014, now abandoned, which is a continuation application of U.S. application Ser. No. 12/516,401, filed on Jul. 12, 2010, now abandoned, which is a U.S. national phase application of International Application No. PCT/IB2007/004353, filed on Nov. 28, 2007, which claims priority to GB Application No. 0623731.7, filed on Nov. 28, 2006. The disclosure of each of the above applications is incorporated herein by reference in its entirety.

US Referenced Citations (162)
Number Name Date Kind
605436 Kellogg Jun 1898 A
642748 Manners Feb 1900 A
658436 Groth Sep 1900 A
746749 Seidel Dec 1903 A
794641 Ramey Jul 1905 A
902832 Philbrook Nov 1908 A
4820306 Gorman et al. Apr 1989 A
5797392 Keldmann et al. Aug 1998 A
6648848 Keldmann et al. Nov 2003 B1
6715485 Djupesland Apr 2004 B1
D530815 Murphy et al. Oct 2006 S
7347201 Djupesland Mar 2008 B2
7377901 Djupesland et al. May 2008 B2
7481218 Djupesland Jan 2009 B2
7543581 Djupesland Jun 2009 B2
7740014 Djupesland Jun 2010 B2
7784460 Djupesland et al. Aug 2010 B2
7841337 Djupesland Nov 2010 B2
7854227 Djupesland Dec 2010 B2
7934503 Djupesland et al. May 2011 B2
7975690 Djupesland Jul 2011 B2
8047202 Djupesland Nov 2011 B2
8146589 Djupesland Apr 2012 B2
8171929 Djupesland et al. May 2012 B2
8327844 Djupesland Dec 2012 B2
8511303 Djupesland Aug 2013 B2
8522778 Djupesland Sep 2013 B2
8550073 Djupesland Oct 2013 B2
8555877 Djupesland Oct 2013 B2
8555878 Djupesland Oct 2013 B2
8590530 Djupesland et al. Nov 2013 B2
8596278 Djupesland Dec 2013 B2
8800555 Djupesland Aug 2014 B2
8875704 Djupesland et al. Nov 2014 B2
8899229 Djupesland et al. Dec 2014 B2
8910629 Djupesland et al. Dec 2014 B2
D723156 Djupesland et al. Feb 2015 S
D725769 Djupesland et al. Mar 2015 S
8978647 Djupesland et al. Mar 2015 B2
9010325 Djupesland et al. Apr 2015 B2
9038630 Djupesland et al. May 2015 B2
9067034 Djupesland et al. Jun 2015 B2
9072857 Djupesland Jul 2015 B2
9108015 Djupesland Aug 2015 B2
9119932 Djupesland Sep 2015 B2
9132249 Djupesland Sep 2015 B2
9144652 Djupesland et al. Sep 2015 B2
9168341 Djupesland Oct 2015 B2
9205208 Djupesland Dec 2015 B2
9205209 Djupesland Dec 2015 B2
9272104 Djupesland Mar 2016 B2
D759805 Djupesland Jun 2016 S
D761951 Djupesland Jul 2016 S
9452272 Djupesland et al. Sep 2016 B2
9468727 Djupesland Oct 2016 B2
D773644 Djupesland Dec 2016 S
9522243 Djupesland Dec 2016 B2
9566402 Djupesland Feb 2017 B2
9649456 Djupesland et al. May 2017 B2
D809128 Djupesland Jan 2018 S
9949923 Djupesland Apr 2018 B2
20040024330 Djupesland et al. Feb 2004 A1
20040112378 Djupesland Jun 2004 A1
20040112379 Djupesland Jun 2004 A1
20040112380 Djupesland Jun 2004 A1
20040149289 Djupesland Aug 2004 A1
20040182388 Djupesland Sep 2004 A1
20050028812 Djupesland Feb 2005 A1
20050072430 Djupesland Apr 2005 A1
20050235992 Djupesland Oct 2005 A1
20060096589 Djupesland May 2006 A1
20060107957 Djupesland May 2006 A1
20060169278 Djupesland et al. Aug 2006 A1
20060219240 Djupesland Oct 2006 A1
20060219241 Djupesland Oct 2006 A1
20060225732 Djupesland Oct 2006 A1
20060231094 Djupesland Oct 2006 A1
20070039614 Djupesland Feb 2007 A1
20070125371 Djupesland Jun 2007 A1
20070186927 Djupesland et al. Aug 2007 A1
20080161771 Djupesland Jul 2008 A1
20080163874 Djupesland Jul 2008 A1
20080221471 Djupesland et al. Sep 2008 A1
20080223363 Djupesland Sep 2008 A1
20080289629 Djupesland et al. Nov 2008 A1
20090101146 Djupesland Apr 2009 A1
20090293873 Djupesland et al. Dec 2009 A1
20090304802 Djupesland et al. Dec 2009 A1
20090314293 Djupesland Dec 2009 A1
20090320832 Djupesland Dec 2009 A1
20100035805 Hafner Feb 2010 A1
20100051022 Djupesland et al. Mar 2010 A1
20100057047 Djupesland et al. Mar 2010 A1
20100199984 Williams et al. Aug 2010 A1
20100242959 Djupesland et al. Sep 2010 A1
20100282246 Djupesland et al. Nov 2010 A1
20100288275 Djupesland et al. Nov 2010 A1
20100300439 Djupesland et al. Dec 2010 A1
20110023869 Djupesland Feb 2011 A1
20110053827 Hafner Mar 2011 A1
20110088690 Djupesland et al. Apr 2011 A1
20110088691 Djupesland Apr 2011 A1
20110114087 Djupesland et al. May 2011 A1
20110120456 Immel May 2011 A1
20110126830 Djupesland et al. Jun 2011 A1
20110259329 Djupesland et al. Oct 2011 A1
20110318345 Djupesland Dec 2011 A1
20120000459 Djupesland Jan 2012 A1
20120006323 Djupesland Jan 2012 A1
20120073571 Djupesland Mar 2012 A1
20120090608 Djupesland et al. Apr 2012 A1
20120260915 Djupesland Oct 2012 A1
20130098362 Djupesland et al. Apr 2013 A1
20130125889 Djupesland et al. May 2013 A1
20130327320 Djupesland Dec 2013 A1
20140018295 Djupesland Jan 2014 A1
20140041660 Djupesland et al. Feb 2014 A1
20140060536 Djupesland Mar 2014 A1
20140073562 Djupesland Mar 2014 A1
20140144442 Djupesland et al. May 2014 A1
20140144443 Djupesland et al. May 2014 A1
20140166008 Djupesland Jun 2014 A1
20140202456 Djupesland Jul 2014 A1
20140246022 Djupesland et al. Sep 2014 A1
20150007811 Djupesland et al. Jan 2015 A1
20150013670 Djupesland et al. Jan 2015 A1
20150013677 Djupesland et al. Jan 2015 A1
20150053201 Djupesland et al. Feb 2015 A1
20150090259 Djupesland et al. Apr 2015 A1
20150101605 Djupesland et al. Apr 2015 A1
20150144129 Djupesland et al. May 2015 A1
20150165139 Hafner Jun 2015 A1
20150182709 Djupesland Jul 2015 A1
20150246194 Djupesland et al. Sep 2015 A1
20150367090 Djupesland et al. Dec 2015 A1
20150367091 Djupesland et al. Dec 2015 A1
20160001022 Djupesland et al. Jan 2016 A1
20160045687 Djupesland Feb 2016 A1
20160051778 Djupesland et al. Feb 2016 A1
20160074603 Djupesland et al. Mar 2016 A1
20160082206 Djupesland et al. Mar 2016 A1
20160082207 Djupesland et al. Mar 2016 A1
20160095989 Djupesland Apr 2016 A1
20160095993 Djupesland Apr 2016 A1
20160101249 Djupesland Apr 2016 A1
20160166788 Djupesland et al. Jun 2016 A1
20160184537 Djupesland Jun 2016 A1
20160193435 Djupesland Jul 2016 A1
20160250408 Djupesland Sep 2016 A1
20160263334 Djupesland Sep 2016 A1
20160279357 Djupesland Sep 2016 A1
20160310683 Djupesland et al. Oct 2016 A1
20160331916 Djupesland et al. Nov 2016 A1
20160367771 Djupesland Dec 2016 A1
20160367772 Djupesland Dec 2016 A1
20160367774 Djupesland et al. Dec 2016 A1
20170043108 Djupesland et al. Feb 2017 A1
20170151397 Djupesland Jun 2017 A1
20170203061 Djupesland et al. Jul 2017 A1
20170216540 Djupesland Aug 2017 A1
20170274164 Djupesland et al. Sep 2017 A1
20170333649 Djupesland Nov 2017 A1
Foreign Referenced Citations (46)
Number Date Country
2 381 460 May 2003 GB
2 404 867 Feb 2005 GB
2 418 147 Mar 2006 GB
WO 9622802 Aug 1996 WO
WO 9853869 Dec 1998 WO
WO 0051672 Sep 2000 WO
WO 0197689 Dec 2001 WO
WO 02068029 Sep 2002 WO
WO 02068030 Sep 2002 WO
WO 02068031 Sep 2002 WO
WO 02068032 Sep 2002 WO
WO 03000310 Jan 2003 WO
WO 03020350 Mar 2003 WO
WO 03082393 Oct 2003 WO
WO 03084591 Oct 2003 WO
WO 03090812 Nov 2003 WO
WO 2004004814 Jan 2004 WO
WO 2004004922 Jan 2004 WO
WO 2004060433 Jul 2004 WO
WO 2004103447 Dec 2004 WO
WO 2005016423 Feb 2005 WO
WO 2005021059 Mar 2005 WO
WO 2006030210 Mar 2006 WO
WO 2006090149 Aug 2006 WO
WO 2007083073 Jul 2007 WO
WO 2007093784 Aug 2007 WO
WO 2007093791 Aug 2007 WO
WO 2007099361 Sep 2007 WO
WO 2007102089 Sep 2007 WO
WO 2007107887 Sep 2007 WO
WO 2007125318 Nov 2007 WO
WO 2007141541 Dec 2007 WO
WO 2008012531 Jan 2008 WO
WO 2008065403 Jun 2008 WO
WO 2008081326 Jul 2008 WO
WO 2008081327 Jul 2008 WO
WO 2008122791 Oct 2008 WO
WO 2008122795 Oct 2008 WO
WO 2009044172 Apr 2009 WO
WO 2010029441 Mar 2010 WO
WO 2012035427 Mar 2012 WO
WO 2012123819 Sep 2012 WO
WO 2013124491 Aug 2013 WO
WO 2013124492 Aug 2013 WO
WO 2013124493 Aug 2013 WO
WO 2014155192 Oct 2014 WO
Non-Patent Literature Citations (28)
Entry
Cindy H. Dubin, Nothing to Sneeze At, Pharmaceutical Formulation & Quality Magazine (Jan. 29, 2003).
Per Gisle Djupesland, Nasal Delivery of Vaccines, EPC (Jan. 29, 2003).
Per Gisle Djupesland, Who Nose How Far Nasal Delivery Can Go?, EPC (Oct. 7, 2003).
Per Gisle Djupesland, Bi-directional Nasal Drug Delivery, Innovations in Pharmaceutical Technology (Jul. 10, 2004).
P.G. Djupesland, Bi-Directional Nasal Delivery of Aerosols Can Prevent Lung Deposition, Journal of Aerosol Medicine (Sep. 2004).
Bi-Directional Nasal Device Delivers Drug on Exhalation, Pharmaceutical Technology (Sep. 10, 2004).
Ola Dale et al., Intranasal Midazolam: A Comparison of Two Delivery Devices in Human Volunteers, Journal of Pharmacy and Pharmacology (Oct. 2004).
G. Furness, Nasal Drug Delivery: Rapid Onset Via a Convenient Route, ONdrugDelivery Ltd. (2005).
M. Kleven, Using Computational Fluid Dynamics (CFD) to Improve the Bi-Directional Nasal Drug Delivery Concept, Trans IChemE Part C. (Jun. 2005).
Per Gisle Djupesland, Breath-Actuated Bi-Directional Delivery Sets the Nasal Market on a New Course, ONdrugDelivery (Oct. 10, 2005).
Hilde Bakke et al., Oral Spray Immunization May be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies But Not Nasal Mucosal or Cellular Immunity, Scan J. of Immunol. (Mar. 2006).
P.G. Djupesland et al., Breath Actuated Nasal Device Improves Delivery to Target Sites Beyond the Nasal Valve, The Laryngoscope (Mar. 2006).
R. Luthringer et al., Rapid Absorption of Sumatriptan Powder and Effects on Glyceryl tinitrate Model of Headache Following Intranasal Delivery Using a Novel Bi-Directional Device, Journal of Pharmacy and Pharmacology (Jan. 2009).
A. Skretting et al., A New Method for Scintigraphic Quantification of Deposition and Clearance in Anatomical Regions of the Human Nose, Nuclear Medicine Communications (Aug. 2009).
Vlckovia et al., Effective Treatment of Mild-to-Moderate Nasal Polyposis with Fluticasone Delivered by a Novel Device, Rhinology (Oct. 22, 2009).
Per Gisle Djupesland et al., Impact of Baseline Nasal Polyp Size and Previous Surgery on Efficacy of Fluticasone Delivered With a Novel Device: A Subgroup Analysis, Am. J. Rhinology Allergy (2010).
P.G. Djupesland et al., Intranasal Sumatriptan Powder Delivered by a Novel Breath Actuated Bi-Directional Device for the Acute Treatment of Migraine: A Randomised Placebo-Controlled Study, Cephalalgia (Mar. 17, 2010).
F.S. Hansen et al., Preliminary Efficacy of Fluticasone Delivered by a Novel Device in Recalcitrant Chronic Rhinosinusitis, Rhinology (Jun. 26, 2010).
Per Gisle Djupesland, Nasal Drug Delivery Devices: Characteristics and Performance in Clinical Perspective—A Review, Drug. Deliv. and Transl. Res. (Oct. 18, 2012).
Per Gisle Djupesland, Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray Pump, Journal of Aerosol Medicine and Pulmonary Drug Delivery (Nov. 2012).
Stewart J. Tepper, Clinical Implications for Breath-Powered Powder Sumatriptan Intranasal Treatment, Headache, The American Headache Society (Apr. 29, 2013).
Mohammad Obaidi et al., Improved Pharmacokinetics of Sumatriptan With Breath Powered Nasal Delivery of Sumatriptan Powder, Headache, The American Headache Society (May 24, 2013).
Per Gisle Djupesland, Breath Powdered Nasal Delivery: A New Route to Rapid Headache Relief, Headache, The American Headache Society (Jun. 4, 2013).
Per Gisle Djupesland et al., The Nasal Approach to Delivering Treatment for Brain Diseases: An Anatomic, Physiologic, and Delivery Technology Overview, Therapeutic Delivery (2014).
R.K. Cady et al., A Randomized Double-Blind, Placebo Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The Target Study), Headache (Sep. 8, 2014).
S.J. Tepper et al., AVP-825 Breath-Powdered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs. 100 mg Oral Sumatripta in the Acute Treatment of Migraines (The Compass Study): A Comparative Randomized Clinical Trial Across Multiple Attacks, Headache: The Journal of Head and Face Pain (Mar. 29, 2015).
D. S. Quintana et al., Low-dose Oxytocin Delivered Intranasally with Breath Powdered Device Affects Social-Cognitive Behavior: A Randomized Four-Way Crossover Trial with Nasal Cavity Dimension Assessment, Transl Psychiatry (Jul. 14, 2015).
R. Mahmoud, Breathe Out, Innovations in Phar, Tech. (Dec. 10, 2015).
Related Publications (1)
Number Date Country
20190099565 A1 Apr 2019 US
Continuations (3)
Number Date Country
Parent 15133356 Apr 2016 US
Child 15936251 US
Parent 14171554 Feb 2014 US
Child 15133356 US
Parent 12516401 US
Child 14171554 US